nimesulide has been researched along with Pelvic Inflammatory Disease in 4 studies
nimesulide: structure
nimesulide : An aromatic ether having phenyl and 2-methylsulfonamido-5-nitrophenyl as the two aryl groups.
Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
Excerpt | Relevance | Reference |
---|---|---|
"400 patients aged 18 to 71 years took part in a multicentre noncomparative study designed to assess the clinical efficacy and tolerability of nimesulide in gynaecological inflammatory disease: adnexitis (72 patients), cervicitis (78 patients), endometritis (18 patients), myometritis (22 patients), and combined disorders (210 patients)." | 9.07 | Nimesulide in the treatment of pelvic inflammatory diseases. A multicentre clinical trial conducted in Campania and Sicily. ( Chiantera, A; Di Leo, S; Meli, MT; Scaricabarozzi, I; Tesauro, R, 1993) |
"400 patients aged 18 to 71 years took part in a multicentre noncomparative study designed to assess the clinical efficacy and tolerability of nimesulide in gynaecological inflammatory disease: adnexitis (72 patients), cervicitis (78 patients), endometritis (18 patients), myometritis (22 patients), and combined disorders (210 patients)." | 5.07 | Nimesulide in the treatment of pelvic inflammatory diseases. A multicentre clinical trial conducted in Campania and Sicily. ( Chiantera, A; Di Leo, S; Meli, MT; Scaricabarozzi, I; Tesauro, R, 1993) |
"Treatment with nimesulide produced good results in all pathologies, significantly reducing the intensity of symptomatology." | 2.67 | [A Sicilian multicenter study of the clinical effectiveness and tolerability of nimesulide in gynecologic inflammatory diseases]. ( Bedoschi, D; Di Leo, S; Meli, MT; Scaricabarozzi, I, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiantera, A | 2 |
Tesauro, R | 2 |
Di Leo, S | 3 |
Meli, MT | 3 |
Scaricabarozzi, I | 2 |
Bedoschi, D | 1 |
Dal PrĂ , ML | 2 |
Santangelo, C | 1 |
4 trials available for nimesulide and Pelvic Inflammatory Disease
Article | Year |
---|---|
Nimesulide in the treatment of pelvic inflammatory diseases. A multicentre clinical trial conducted in Campania and Sicily.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Middle Aged; Pelvi | 1993 |
[A Sicilian multicenter study of the clinical effectiveness and tolerability of nimesulide in gynecologic inflammatory diseases].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Drug Evaluation; Endometri | 1990 |
[Clinical experience with nimesulide in gynecologic inflammatory pathology].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Double-B | 1988 |
[New therapeutic prospects in gynecologic inflammation: nimesulide].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Double-Blind M | 1988 |